Photobiomodulation / low-level laser therapy
Application of specific light wavelengths to tissue, positioned honestly as supportive rather than curative, within select pain and recovery contexts.
What it is & how it works
Application of specific light wavelengths (red or near-infrared) to tissue, intended to support cellular energy metabolism and reduce localized inflammation, thereby supporting tissue- and cellular-level recovery.
How it's done
Typically administered as outpatient sessions of roughly 10–20 minutes, two to three times weekly over several weeks, using a handheld or panel device applied directly to the treatment area by a clinician or trained technician; no anaesthesia or downtime is required.
Conditions it treats
Why Brain Bridge
Offered as one adjunct among several in Brain Bridge's multi-modality approach, positioned honestly as supportive rather than curative, in keeping with the clinic's evidence-bounded language.
Evidence & safety
Adjunct only; evidence is indication-specific. In autism, photobiomodulation is an off-label use with early, developing evidence; it is considered only alongside core developmental therapy and after discussion with the family.
Related questions
No — photobiomodulation is painless and non-invasive, with no anaesthesia or downtime required, and it's generally well tolerated. Evidence on optimal dosing and expected benefit still varies by condition and continues to develop.
Evidence varies by condition — several systematic reviews report reduced pain scores for certain musculoskeletal conditions — but protocols, wavelengths, and devices differ considerably across studies, which is why it's offered as a supportive adjunct rather than a primary treatment.